Quince Therapeutics's total assets for Q4 2025 were $93.52M, a decrease of -14.90% from the previous quarter. QNCX total liabilities were $129.24M for the fiscal quarter, a 18.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.